Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (Split Virion and Inactivated) Produced at Butantan Institute

NCT03057483 is registered in ClinicalTrials.gov with Butantan Institute as lead sponsor.

NCT NCT03057483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03057483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active Surveillance for Adverse Events Following Immunization With the Trivalent Influenza Vaccine (Split Virion and Inactivated) Produced at Butantan Institute
Lead sponsor
Butantan Institute
Phase
Observational
Overall status
Completed
Start date
April 6, 2017
Completion date
December 6, 2017
Enrollment
533 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

influenza vaccines